Review
[New drugs in type 2 diabetes mellitus therapy]
[Article in
Czech]
Affiliations
- PMID: 24007229
Item in Clipboard
Review
[New drugs in type 2 diabetes mellitus therapy]
[Article in
Czech]
Vnitr Lek.
2013 Aug.
Abstract
The objective in developing a new type 2 diabetes therapy is to achieve greater safety and better efficacy. Newly registered drugs include lixisenatide, QW exenatide, dapagliflozin and insulin degludec. Once weekly gliptins and other substances are under development.
Similar articles
-
Dapagliflozin once daily plus exenatide once weekly in obese adults without diabetes: Sustained reductions in body weight, glycaemia and blood pressure over 1 year.Diabetes Obes Metab. 2017 Sep;19(9):1276-1288. doi: 10.1111/dom.12954. Epub 2017 May 31. Diabetes Obes Metab. 2017. PMID: 28345814 Free PMC article. Clinical Trial.
-
Diabetes News.J Diabetes. 2017 Feb;9(2):111-114. doi: 10.1111/1753-0407.12495. Epub 2016 Nov 21. J Diabetes. 2017. PMID: 27763720 No abstract available.
-
Dapagliflozin once-daily and exenatide once-weekly dual therapy: A 24-week randomized, placebo-controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes.Diabetes Obes Metab. 2017 Jan;19(1):49-60. doi: 10.1111/dom.12779. Epub 2016 Sep 26. Diabetes Obes Metab. 2017. PMID: 27550386 Free PMC article. Clinical Trial.
-
Understanding the impact of commonly utilized, non-insulin, glucose-lowering drugs on body weight in patients with type 2 diabetes.Expert Opin Pharmacother. 2018 Jul;19(10):1087-1095. doi: 10.1080/14656566.2018.1494727. Epub 2018 Jul 11. Expert Opin Pharmacother. 2018. PMID: 29958007 Review.
-
Effectiveness and Safety of Newer Antidiabetic Medications for Ramadan Fasting Diabetic Patients.J Diabetes Res. 2016;2016:6962574. doi: 10.1155/2016/6962574. Epub 2016 Aug 24. J Diabetes Res. 2016. PMID: 27642611 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
